Clinical Trials Browser

Phase 1/2 × Multiple Myeloma × tetrathiomolybdate × Clear all

NCT00352742 2008-10-28

A Study of ATN-224 and Bortezomib in Patients With Multiple Myeloma

Phase 1/2 Terminated

Multiple Myeloma, Recurrence